Study for Mechanisms of Sepsis

Inhibitory effects of curcumin and mechanism of alveolar macrophages in patients with sepsis NF- kappa B activation by Nrf2

Status

Recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-CIC-16007873

Enrollment

Unknown

Registered

2016-02-01

Start date

2016-02-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

three:curcumin

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Admitted to our hospital ICU patients diagnosed with sepsis

Exclusion criteria

Exclusion criteria: age less than 18 years old

Design outcomes

Primary

Measure	Time frame
IL-1;	—

Countries

China

Contacts

Public ContactLi Caixia

licaixiadoctor@sina.com+86 15268118258

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026